What We're Reading: Page 211
Industry reads hand-picked by our editors
Jan 13, 2020
-
The New York Times
At 16, She's a Pioneer in the Fight to Cure Sickle Cell Disease
-
The Wall Street Journal
Drugmakers Test New Ways to Pay for Six-Figure Treatments
-
STAT
Agios CEO forecasts 'line of sight' to more approved drugs and profits
-
POLITICO
NIDA director: New pain meds are still years away
Jan 10, 2020
Jan 09, 2020
-
STAT
The ghosts of JPMs past: How 20 years of deals have shaped health care
-
Fortune
Pharma: Stop Chasing Shiny Objects and Embrace Practical Tech
-
The Wall Street Journal
California Looks to Launch Its Own Prescription-Drug Label
-
Reuters
'Gold rush': Race is on for health data in East Europe's frontier market
Jan 08, 2020
-
The Wall Street Journal
A New Approach to Cancer Treatment Draws Lessons From Darwin
-
Los Angeles Magazine
UCLA's Xtandi Patent Fight Could Make the Medicine Inaccessible in India
-
BioCentury
Why over 200 biopharma leaders have signed onto a new commitment to patients
-
C&EN
n-Lorem Foundation launches to develop individualized therapies for ultra-rare diseases
Jan 07, 2020
Jan 06, 2020
Jan 03, 2020
-
The Wall Street Journal
FDA’s Deadline Problem?
-
FiercePharma
Regeneron to lay off field staffers as it restructures Sanofi partnership
-
Bloomberg
Carcinogen in Zantac May Build During Storage, Lab Finds
-
Reuters
Novo Nordisk to offer free insulin to U.S. patients in immediate need
Previous
